dc.identifier.citation |
1. ICH-International Conference on Harmonization, of Technical Requirements for registration of Pharmaceuticals for Human Use Topic Q2 (R1), Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland, 2005. 2. Naber, D. and Lambert, M. (2004). Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry. 28(8): 1213-1219. 3. DeLeon, A., Patel, N.C. and Crismon, M.L. (2004). Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Therap. 26(5): 649-666. 4. Sweetman, S.C. (2005). Martindale” The Complete Drug Reference”. London, Pharmaceutical Press.p. 5. Mondal, P., Rani, S.S. and Alekhya, K. (2013). A new stability indicating validated method for the determination of Aripiprazole in bulk and tablet dosage form using RP- HPLC. Int J Pharm Pharm Sci. 5(4): 660-665. 6. Narayana, M.B.V. and Chandrasekhar, K.B. (2012). A Validated specific stability-indicating RP-HPLC method for Aripiprazole and its related substances. J Chem Pharm Res. 4(9): 4426- 4435. 7. Pai, N.R. and Dubhashi, D.S. (2010). Development of stability indicating, validated HPLC method for quantitative determination of Aripiprazole and its impurities. Der Pharmacia Lettre. 2 (4): 1-10. 8. Helmy, A.G., Abdel-Gawad, F.M. and Mohamed, E.F. (2012). Spectrophotometric study on determination of Aripiprazole in tablets by charge-transfer and ion-pair complexation reactions with some acceptors. Asian J. Pharm. Ana. 2(1): 12-19. 9. Jain, R.,. Kashaw, S.K., Jain, R., Mishra, P. and Kohli, D.V. (2011). Visible spectrophotometric method for the determination of Aripiprazole in tablets. Indian J Pharm Sci. 73(1): 74-76. 10. Kalaichelvi, R., Thangabalan, B., Rao, D.S. and Jayachandran, E. (2009). UV spectrophotometric determination of Aripiprazole in bulk and pharmaceutical formulation. E-J.Chem. 6(S1): S87-S90. 11. Sandeep, K., Induri, M. and Sudhakar, M. (2013). Validated spectrophotometric quantification of Aripiprazole in pharmaceutical formulations by using multivariate technique. Adv Pharm Bull. 3(2): 469-472. 12. Kalaichelvi, R., Thangabalan, B. and Rao, D.S. (2010). Validated RP-HPLC method for analysis of Aripiprazole in a formulation. E-J.Chem. 7(3): 827-832. 13. Kubo, M., Mizooku, Y., Hirao, Y. and Osumi, T. (2005). Development and validation of an LC-MS/MS method for the quantitative determination of Aripiprazole and its main metabolite, OPC-14857, in human plasma. J. Chromatogr. B. 822(1-2): 294-299. 14. Patel, D.P., Sharma, P., Sanyal, M. and Shrivastav, P.S. (2013). SPE-UPLC-MS/MS method for sensitive and rapid determination of Aripiprazole in human plasma to support a bioequivalence study. J. Chromatogr. B. 925: 20-25. 15. Asangil, D., Tasdemir, I.H. and Kiliç, E. (2012). Adsorptive stripping voltammetric methods for determination of Aripiprazole. J. Pharm. Anal. 2(3): 193-199. 16. Merli, D., Dondi, D., Ravelli, D., Tacchini, D. and Profumo, A. (2013). Electrochemistry and analytical determination of Aripiprazole and Octoclothepin at glassy carbon electrode.J. Electroanal. Chem. 711: 1-7. 17. M.Amer, S., El-Maraghy, C.M., Salem, H. and Nebsen, M. (2016). Quantitative determination of citalopram hydrobromide by spectrophotometry and chemometry in presence of its degradation products and additives in pharmaceutical preparation. Analytical Chemistry: An Indian Journal. 16(2): 53-62. 18. Miller, J.N. and Miller, J.C. (2005). Statistics and Chemometrics for Analytical Chemistry. England, Harlow, Pearson Education Limited. |
en_US |